Wordt geladen...
Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
Retrospective analysis of the long-term results of a randomized controlled trial comparing alemtuzumab (ALEM) and antithymocyte globulin (ATG) as induction therapy in simultaneous pancreas-kidney transplantation (SPK) to address individualized long-term immunosuppression. Between 2006 and 2010 a tot...
Bewaard in:
| Gepubliceerd in: | Ann Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
International Scientific Literature, Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6363467/ https://ncbi.nlm.nih.gov/pubmed/30679414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.911712 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|